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Panama	 remains	 free	 of	 zoonotic	 tuberculosis	 caused	
by Mycobacterium bovis.	However,	DNA	fingerprinting	of	
7	M. bovis	 isolates	 from	a	2013	bovine	 tuberculosis	out-
break indicated minimal homology with strains previously 
circulating	 in	 Panama.	M. bovis	 dispersion	 into	 Panama	
highlights the need for enhanced genotype testing to track 
zoonotic infections.
Zoonotic tuberculosis (TB) is a chronic infectious dis-ease of humans caused by transmission of Mycobac-
terium bovis from cattle (1). M. bovis infection in humans 
occurs after direct contact with infected cattle, ingestion of 
unpasteurized dairy products or raw or undercooked meat, 
or (rarely) person-to-person transmission (2). Despite the 
low incidence of zoonotic tuberculosis in the Americas, 
accumulating evidence confirms that death rates from M. 
bovis pulmonary infection in specific groups and settings, 
including in the United States and Mexico, are substantial 
(3,4). The risk for death is twice as high for children and 
persons with HIV co-infection and extrapulmonary TB 
than for HIV-negative persons with TB (3). M. bovis in-
fection in cattle (bovine TB) has a major effect on meat 
and live animal export trade and dairy industry develop-
ment and expansion (1). Thus, bovine TB eradication plans 
across the Americas are based on the elimination of any 
cattle with a positive tuberculin skin test (TST) result (5). 
The most recently reported bovine TB outbreak in 
Panama occurred in 1997 in the western province of Bocas 
del Toro. The origin of this outbreak remains unclear. Since 
2008 (after the slaughter of ≈7,000 cattle during the 1997 
outbreak), Panama has not reported any bovine TB cases to 
the World Organisation for Animal Health (OIE) (Figure 
1) (6). However, Panama has not received bovine TB-free 
accreditation. OIE data show that clinical bovine TB was 
continually reported from Colombia and Costa Rica during 
the same period (6). 
In August 2013, despite active surveillance at coun-
try borders and in-country animal health controls, a new 
bovine TB outbreak in Panama was reported to OIE (6). 
Neither the neighboring countries of Colombia and Costa 
Rica nor Panama have reported zoonotic tuberculosis to 
OIE in the past 20 years (4,7). Among these countries, only 
Costa Rica does not test M. tuberculosis complex isolates 
to identify M. bovis. In contrast, Guatemala continually re-
ports cases of zoonotic TB (6). Yet, the genetic biodiver-
sity of M. bovis in Central America remains unexplored. 
Comparisons of mycobacterial interspersed repetitive 
unit–variable-number tandem-repeat (MIRU-VNTR) and 
single-nucleotide polymorphism (SNP) analyses based on 
whole-genome sequencing have proven to be helpful for 
identifying TB outbreaks elsewhere (8,9). We character-
ized and genotyped M. bovis isolates that reemerged in 
Panama during the 2013 outbreak of bovine TB.
The Study
In March 2013, as part of the Panamanian bovine TB con-
trol program, TSTs were administered to a dairy herd of 
1,680 Jersey cows in Coclé Province, Panama. Animals 
with TST indurations >4 mm in diameter were considered 
positive. From animals with positive TST results, blood 
samples were collected for confirmation with an interfer-
on-gamma release assay (BOVIGAM; Prionics, La Vista, 
NE, USA). Bovine TB was confirmed for 9 animals, 1 of 
which died naturally and 8 of which were sent to slaughter 
for postmortem examination and collection of samples for 
M. bovis culture. Epidemiologic investigation revealed that 
within the past 2 years, all 9 animals had been imported 
from Guatemala and Costa Rica according to controlled 
and legal commercial trade protocols. Visible lesions were 
found on all 8 slaughtered animals. Samples were obtained 
and sent for culture at the Laboratorio de Diagnóstico e In-
vestigación Veterinaria de Salud Animal del Ministerio de 
Desarrollo Agropecuario.
Mycobacteria were isolated from 7 animals. Bacterial 
genomic DNA was extracted, and PCR identified the iso-
lates as M. bovis (10). DNA from the M. bovis isolates was 
genotyped by 24-loci MIRU-VNTR (11). Whole-genome 
sequencing was performed by using the Illumina MiSeq 
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platform (12), and sequencing reads were aligned on 
reference genome by using the bowtie2 program (http://
bowtie-bio.sourceforge.net/bowtie2/index.shtml) and for 
further SNP calling and variant cell format file processing by 
using a combination of SAMtools (http://samtools.source-
forge.net) and VCFtools (http://vcftools.source¬forge.net). 
M. bovis genome sequence NC_002945.3 was used as a 
reference for SNP/indel detection. Sequencing data for 
the M. bovis sequenced genomes were deposited in the 
National Center for Biotechnology Information Sequence 
Read Archive (accession no. PRJNA267480). SNP analy-
sis revealed high homology among the 7 M. bovis isolates. 
However, the isolates were not directly related to 2 M. bo-
vis isolates available from the 1997 bovine TB outbreak in 
Bocas del Toro (Figure 2).
Among the 7 isolates, a least four 24-loci MIRU-
VNTR M. bovis genotypes were identified, including 5 
distinct loci sequences (Table, http://wwwnc.cdc.gov/EID/
article/21/6/14-1821-T1.htm). These 4 distinct genotypes 
suggest that bovine TB may have been introduced by at 
least 4 infected animals. The M. bovis strains obtained from 
animals imported from Guatemala were clustered accord-
ing to MIRU-VNTR genotypes (Table). Similarly, MIRU-
VNTR genotypes for M. bovis isolates obtained from 3 ani-
mals imported from Costa Rica were more closely related. 
The 2 M. bovis isolates from the 1997 Bocas del Toro out-
break shared the same MIRU-VNTR genotypes with those 
from the recent outbreak. The molecular clock speed for 
this genotyping tool may account for the lack of differentia-
tion in this last comparison, but we cannot rule out endemic 
spread of the same strain in this herd.
SNP analysis revealed high genetic similarity among 
all 7 M. bovis isolates from the 2013 bovine TB outbreak. 
In contrast, we found no direct relation between M. bovis 
isolates from the 2013 and 1997 outbreaks. Because all 7 
isolates were grouped in 2 branches, it is possible that they 
were derived from a common ancestor in Central America. 
A comparison of the SNPs from the 7 M. bovis isolates 
from the 2013 outbreak with 2 M. bovis isolates from the 
1997 Bocas del Toro outbreak showed no close relation-
ships. Adjacent countries have often reported M. bovis 
strains with highly similar genotypes, but geographically 
distant countries have not (13). 
We hypothesize that similar genotypes are being dis-
tributed in Central America because of augmented commer-
cial trade between neighboring countries. Coincidentally, 
since January 2013, importation of cattle from Nicaragua, 
the United States, and Costa Rica into Panama for dairy 
and meat production has increased by ≈300%. Unfortu-
nately, whole-genome sequencing data for M. bovis iso-
lates from Central America are not available for validation 
of this hypothesis. Determination of the genetic structure 
of all M. bovis strains circulating in Central America will 
require further multicenter studies.
Conclusions
The diagnosis of bovine TB in Panama requires urgent at-
tention. Accumulated genetic changes in M. bovis isolates 
from 2 outbreaks occurred 15 years apart (8). Currently in 
Latin America, use of the TST remains the preferred meth-
od of identifying animals with bovine TB, despite its sen-
sitivity range of 68% to 95% (14,15). In addition, several 
factors can lead to false-positive and false-negative TST 
results (e.g., purified protein derivative antigen quality and 
Figure 1. Bovine	tuberculosis	(TB)	in	Panama,	1999–2013.	Data	
from	the	World	Organisation	for	Animal	Health	(http://www.oie.int/
animal-health-in-the-world/the-world-animal-health-information-
system/the-oie-data-system/).	
Figure 2. Phylogenic	placement	of	the	Mycobacterium bovis 
isolates. The M. bovis	AF2122/97	sequence	was	used	as	a	
reference	for	single-nucleotide	polymorphism	analysis	(GenBank	
accession	no.	NC_002945.3).The	tree	was	derived	from	an	
unweighted pair-grouping method analysis algorithm by using 
DNA	fragment	sequence	analysis.	Numbers	on	branches	
represent bootstrap percentages from 500 replicates. M. 
canettii was used as the outgroup. Evolutionary analyses were 
performed	by	using	MEGA6	software	(http://www.megasoftware.
net).	Symbols	indicate	M. bovis isolates with identical genotypes 
according to mycobacterial interspersed repetitive units–variable 
number of tandem repeats. Scale bar indicates mean distances 
between	strains	according	to	base	substitutions	(%).	CR,	Costa	
Rica;	GUA,	Guatemala,	PTY,	Coclé,	Panama.
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manipulation, skin induration interpretation, and injection 
dose protocols) (15). In contrast, interferon-gamma release 
assays are expensive and cost-prohibitive for rural farmers. 
For detection and quantification of the disease, novel and 
low-cost biomarker-based tests are needed; they would en-
able proper identification and disposal of diseased animals 
to prevent new outbreaks of zoonotic TB. After bovine TB 
is diagnosed, whole-genome sequencing and MIRU-VN-
TR can differentiate M. bovis lineages and identify patterns 
of bovine TB transmission across Central America.
Our study provides the baseline genotypes and se-
quences of M. bovis strains involved in the 2013 outbreak 
of bovine TB in Panama. These data could serve as a refer-
ence to determine future sources of zoonotic M. bovis in-
fection and help track the movement of M. bovis strains 
between Central American countries. Together these strat-
egies will reinforce international bovine TB control and 
eradication efforts.
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